Results 121 to 130 of about 14,917 (246)

Eplerenone in chronic renal disease: the EVALUATE trial [PDF]

, 2010
John W. Funder
openalex   +1 more source

Review of: "Eplerenone Reverses Age-Dependent Cardiac Fibrosis Through Downregulating Osteopontin" [PDF]

, 2021
Anastasios Lymperopoulos
openalex   +1 more source

EPLERENONE TREATMENT FOR SYMPTOMATIC SUBFOVEAL SEROUS PIGMENT EPITHELIAL DETACHMENT

, 2022
Jayant Kumar, Acs Tan, D Simhaee, C Balaratnasingam, K Dansingani, L Yannuzzi, S Mrejen, D Sarraf, S Mukkamala, K Freund, Cmg Cheung, W Lee, H Koizumi, K Dansingani, Tyy Lai, K Freund, F Arif, A Pryds, M Larsen, R Sisk, M Zhao, I Clrier, E Bousquet, S Wang, P Sun, R Tandias, B Seto, J Arroyo, I Chatziralli, A Vlachodimitropoulou, C Daoula, A Haghighi, J Do, H Ameri, A Pryds, S Hamann, M Larsen   +36 more
openalex   +2 more sources

The Anabolic Androgenic Steroid Fluoxymesterone Inhibits 11β-Hydroxysteroid Dehydrogenase 2-Dependent Glucocorticoid Inactivation [PDF]

, 2017
Anabolic androgenic steroids (AAS) are testosterone derivatives used either clinically, in elite sports, or for body shaping with the goal to increase muscle size and strength.
Da Cunha, Thierry, Fürstenberger, Cornelia, Kratschmar, Denise V., Odermatt, Alex, Saugy, Martial, Schuster, Daniela, Vuorinen, Anna   +6 more
core  

Positive effect of eplerenone treatment on endothelial progenitor cells in patients with chronic heart failure [PDF]

, 2012
Christian Jung, Anna Florvaag, Volker Oberle, Michael Fritzenwanger, Daniel Kretschmar, Friedhelm Kuethe, Stefan Betge, Bjoern Goebel, Marcus Franz, Dagmar Barz, Markus Ferrari, Hans R. Figulla   +11 more
openalex   +1 more source

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

ClinicoEconomics and Outcomes Research, 2016
Kostas Athanasakis,1 Aikaterini Bilitou,2 Dawn Lee,3 Eleftheria Karampli,1 Apostolos Karavidas,4 John Parissis,5 Georgia Sykara,2 John Kyriopoulos1 1Department of Health Economics, National School of Public Health, Athens, Greece; 2Pfizer Hellas, Athens,
Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J   +7 more
doaj  

Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability [PDF]

, 2019
Ahmed Khames
openalex   +1 more source

11-Deoxycorticosterone (DOC)’s Action on the Gill Osmoregulation of Juvenile Rainbow Trout (Oncorhynchus mykiss)

Biology
In aquaculture, stress can negatively affect fish growth. For years, the cortisol hormone has been thought to play both glucocorticoid and mineralocorticoid functions. Nevertheless, recent research has suggested that 11-deoxycorticosterone (DOC) released
Rodrigo Zuloaga, Luciano Ahumada-Langer, Jorge Eduardo Aedo, Alfredo Molina, Juan Antonio Valdés   +4 more
doaj   +1 more source

Evidence-based drug therapy in the management of heart failure [PDF]

, 2011
This article provides an update on the drug treatment for heart failure (HF) mostly based on the recent clinical guidelines issued by the National Institute of Clinical Excellence (NICE).1 New high quality evidence from randomised controlled trials has ...
Gauci, Marise
core  

Efficacy of 4 Weeks Therapy with Eplerenone in Resistant Hypertension: Reduction of Aortic Blood Pressure, Arterial Stiffness, and Impact on IL-6 Levels

Artery Research
Background Resistant hypertension affects 10–15% of treated patients and remains a therapeutic challenge. Eplerenone is recommended when spironolactone is ineffective or poorly tolerated.
Stanisław Wasiliew, Dawid Lipski, Łukasz Stryczyński, Artur Radziemski, Jan Królak, Andrzej Tykarski, Paweł Uruski   +6 more
doaj   +1 more source